
Postdoctoral Research Fellow @MayoClinic Women’s Health. MSc Candidate.
Joined July 2023
- Tweets17
- Following23
- Followers33
- Likes20
Regina Castaneda MD retweeted
Menopausal women taking hormone therapy in addition to a GLP-1 medication may see greater and sustained weight loss, a retrospective cohort study suggested.
Read more of our #MenopauseSocietyMtg coverage: medpagetoday.com/meetingcove… @Reginacastamd
Thank you this great conversation! 🙌🏻
Tirzepatide and Menopause| Listen to Maria Daniela Hurtado Andrade, MD, PhD, and Regina Castaneda, MD, discuss whether medications like tirzepatide could be useful and safe for postmenopausal women in this @Endocrine_News Podcast episode: bit.ly/4nJgniv
Regina Castaneda MD retweeted
At #TMS2025, researchers reported menopausal status and hormone therapy use may affect #WeightLoss outcomes with tirzepatide. Women on hormone therapy or pre/perimenopausal lost nearly 20% body weight vs. 15% in untreated postmenopausal peers.
Read more: contemporaryobgyn.net/view/r…
So excited to see my friend and co-fellow embrace this journey❤️
Hi #MedTwitter
I am Jana Karam, a medical graduate from Lebanon 🇱🇧 and a postdoctoral research fellow @MayoClinic @WHMayoClinic
I am very excited to be applying to #OBGYN #Match2026
Happy to connect! Good luck everyone☺️
When evaluating the role of hormone therapy in post menopausal women, understanding the physiological role of estrogen is fundamental. #biorenderforgrants
Regina Castaneda MD retweeted
A Mayo Clinic study reveals combining tirzepatide with hormone therapy boosts weight loss results in postmenopausal women—supporting a more personalized approach to obesity care. #ENDO2025 #Menopause
Read more: contemporaryobgyn.net/view/t…
In a matched cohort of postmenopausal women, concomitant use of menopause hormone therapy and tirzepatide was associated with greater weight loss.
Thanks @EndoMedia for this great press release that showcases our work!
#ENDO2025 @TheEndoSociety
bit.ly/463gUGN










